 | • レポートコード：MRC22NVL18169 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の新型コロナウイルス感染症用迅速抗原検査（RAT）の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の新型コロナウイルス感染症用迅速抗原検査（RAT）市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の新型コロナウイルス感染症用迅速抗原検査（RAT）市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の新型コロナウイルス感染症用迅速抗原検査（RAT）市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の新型コロナウイルス感染症用迅速抗原検査（RAT）市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の新型コロナウイルス感染症用迅速抗原検査（RAT）の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な新型コロナウイルス感染症用迅速抗原検査（RAT）プレーヤーとして、Abbott、 Quidel、 ACCESS BIO、 CTK Biotech、 SD Biosensor、 Ellume、 InBios、 Celltrion、 AESKU.GROUP、 ROCHE、 BD、 OraSure Technologies、 Clip Health、 LumiraDx、 Princeton BioMeditech Corporation、 RapiGEN Inc.、 Orient Gene、 Wondfo Biotech、 Ihealth (Andon Health)、 Wantai BioPharm、 Biotest Biotech、 Shenzhen YHLO Biotechなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの新型コロナウイルス感染症用迅速抗原検査（RAT）市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 蛍光免疫クロマトグラフィー、コロイド金免疫クロマトグラフィー、ラテックス免疫クロマトグラフィー、その他 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 病院、地域検査、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：新型コロナウイルス感染症用迅速抗原検査（RAT）の年間販売量2017-2028、地域別現状・将来分析 ・新型コロナウイルス感染症用迅速抗原検査（RAT）のタイプ別セグメント：蛍光免疫クロマトグラフィー、コロイド金免疫クロマトグラフィー、ラテックス免疫クロマトグラフィー、その他 ・新型コロナウイルス感染症用迅速抗原検査（RAT）のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別セグメント：病院、地域検査、その他 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・企業別のグローバル新型コロナウイルス感染症用迅速抗原検査（RAT）市場データ：2020-2022年の年間販売量、市場シェア ・企業別の新型コロナウイルス感染症用迅速抗原検査（RAT）の年間売上：2020-2022年の売上、市場シェア ・企業別の新型コロナウイルス感染症用迅速抗原検査（RAT）販売価格 ・主要企業の新型コロナウイルス感染症用迅速抗原検査（RAT）生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 新型コロナウイルス感染症用迅速抗原検査（RAT）の地域別レビュー ・地域別の新型コロナウイルス感染症用迅速抗原検査（RAT）市場規模2017-2022：年間販売量、売上 ・主要国別の新型コロナウイルス感染症用迅速抗原検査（RAT）市場規模2017-2022：年間販売量、売上 ・南北アメリカの新型コロナウイルス感染症用迅速抗原検査（RAT）販売の成長 ・アジア太平洋の新型コロナウイルス感染症用迅速抗原検査（RAT）販売の成長 ・欧州の新型コロナウイルス感染症用迅速抗原検査（RAT）販売の成長 ・中東・アフリカの新型コロナウイルス感染症用迅速抗原検査（RAT）販売の成長 南北アメリカ市場 ・南北アメリカの国別の新型コロナウイルス感染症用迅速抗原検査（RAT）販売量、売上（2017-2022） ・南北アメリカの新型コロナウイルス感染症用迅速抗原検査（RAT）の種類別販売量 ・南北アメリカの新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別販売量 ・米国の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・カナダの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・メキシコの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・ブラジルの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 アジア太平洋市場 ・アジア太平洋の国別の新型コロナウイルス感染症用迅速抗原検査（RAT）販売量、売上（2017-2022） ・アジア太平洋の新型コロナウイルス感染症用迅速抗原検査（RAT）の種類別販売量 ・アジア太平洋の新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別販売量 ・中国市場の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・日本市場の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・韓国市場の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・東南アジアの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・インドの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・オーストラリアの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・台湾の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 欧州市場 ・欧州の国別の新型コロナウイルス感染症用迅速抗原検査（RAT）販売量、売上（2017-2022） ・欧州の新型コロナウイルス感染症用迅速抗原検査（RAT）の種類別販売量 ・欧州の新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別販売量 ・ドイツの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・フランスの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・イギリスの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・イタリアの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・ロシアの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 中東・アフリカ市場 ・中東・アフリカの国別の新型コロナウイルス感染症用迅速抗原検査（RAT）販売量、売上（2017-2022） ・中東・アフリカの新型コロナウイルス感染症用迅速抗原検査（RAT）の種類別販売量 ・中東・アフリカの新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別販売量 ・エジプトの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・南アフリカの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・イスラエルの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・トルコの新型コロナウイルス感染症用迅速抗原検査（RAT）市場 ・GCC諸国の新型コロナウイルス感染症用迅速抗原検査（RAT）市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・新型コロナウイルス感染症用迅速抗原検査（RAT）の製造コスト構造分析 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の製造プロセス分析 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・新型コロナウイルス感染症用迅速抗原検査（RAT）の主要なグローバル販売業者 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の主要なグローバル顧客 地域別の新型コロナウイルス感染症用迅速抗原検査（RAT）市場予測レビュー ・地域別の新型コロナウイルス感染症用迅速抗原検査（RAT）市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・新型コロナウイルス感染症用迅速抗原検査（RAT）のタイプ別市場規模予測 ・新型コロナウイルス感染症用迅速抗原検査（RAT）の用途別市場規模予測 主要企業分析 Abbott、 Quidel、 ACCESS BIO、 CTK Biotech、 SD Biosensor、 Ellume、 InBios、 Celltrion、 AESKU.GROUP、 ROCHE、 BD、 OraSure Technologies、 Clip Health、 LumiraDx、 Princeton BioMeditech Corporation、 RapiGEN Inc.、 Orient Gene、 Wondfo Biotech、 Ihealth (Andon Health)、 Wantai BioPharm、 Biotest Biotech、 Shenzhen YHLO Biotech ・企業情報 ・新型コロナウイルス感染症用迅速抗原検査（RAT）製品 ・新型コロナウイルス感染症用迅速抗原検査（RAT）販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Rapid Antigen Testing (RAT) for COVID-19 will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Antigen Testing (RAT) for COVID-19 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Antigen Testing (RAT) for COVID-19 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Rapid Antigen Testing (RAT) for COVID-19 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Rapid Antigen Testing (RAT) for COVID-19 market, reaching US$ million by the year 2028. As for the Europe Rapid Antigen Testing (RAT) for COVID-19 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Rapid Antigen Testing (RAT) for COVID-19 players cover Abbott, Quidel, ACCESS BIO, and CTK Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antigen Testing (RAT) for COVID-19 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Community Testing
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rapid Antigen Testing (RAT) for COVID-19 by Country/Region, 2017, 2022 & 2028
2.2 Rapid Antigen Testing (RAT) for COVID-19 Segment by Type
2.2.1 Fluorescence Immunochromatography
2.2.2 Colloidal Gold Immunochromatography
2.2.3 Latex Immunochromatography
2.2.4 Others
2.3 Rapid Antigen Testing (RAT) for COVID-19 Sales by Type
2.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2017-2022)
2.3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Type (2017-2022)
2.4 Rapid Antigen Testing (RAT) for COVID-19 Segment by Application
2.4.1 Hospitals
2.4.2 Community Testing
2.4.3 Other
2.5 Rapid Antigen Testing (RAT) for COVID-19 Sales by Application
2.5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Market Share by Application (2017-2022)
2.5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Application (2017-2022)
3 Global Rapid Antigen Testing (RAT) for COVID-19 by Company
3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Breakdown Data by Company
3.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Company (2020-2022)
3.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Company (2020-2022)
3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Company (2020-2022)
3.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Company (2020-2022)
3.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Company (2020-2022)
3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sale Price by Company
3.4 Key Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Product Location Distribution
3.4.2 Players Rapid Antigen Testing (RAT) for COVID-19 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region
4.1 World Historic Rapid Antigen Testing (RAT) for COVID-19 Market Size by Geographic Region (2017-2022)
4.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Geographic Region
4.2 World Historic Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country/Region (2017-2022)
4.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue by Country/Region
4.3 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales Growth
4.4 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales Growth
4.5 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Growth
4.6 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Growth
5 Americas
5.1 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Country
5.1.1 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)
5.1.2 Americas Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)
5.2 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Type
5.3 Americas Rapid Antigen Testing (RAT) for COVID-19 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Region
6.1.1 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2017-2022)
6.1.2 APAC Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2017-2022)
6.2 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Type
6.3 APAC Rapid Antigen Testing (RAT) for COVID-19 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rapid Antigen Testing (RAT) for COVID-19 by Country
7.1.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)
7.1.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)
7.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Type
7.3 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 by Country
8.1.1 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2017-2022)
8.2 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Type
8.3 Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rapid Antigen Testing (RAT) for COVID-19
10.3 Manufacturing Process Analysis of Rapid Antigen Testing (RAT) for COVID-19
10.4 Industry Chain Structure of Rapid Antigen Testing (RAT) for COVID-19
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors
11.3 Rapid Antigen Testing (RAT) for COVID-19 Customer
12 World Forecast Review for Rapid Antigen Testing (RAT) for COVID-19 by Geographic Region
12.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size Forecast by Region
12.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Region (2023-2028)
12.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Type
12.7 Global Rapid Antigen Testing (RAT) for COVID-19 Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Quidel
13.2.1 Quidel Company Information
13.2.2 Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Quidel Main Business Overview
13.2.5 Quidel Latest Developments
13.3 ACCESS BIO
13.3.1 ACCESS BIO Company Information
13.3.2 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 ACCESS BIO Main Business Overview
13.3.5 ACCESS BIO Latest Developments
13.4 CTK Biotech
13.4.1 CTK Biotech Company Information
13.4.2 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 CTK Biotech Main Business Overview
13.4.5 CTK Biotech Latest Developments
13.5 SD Biosensor
13.5.1 SD Biosensor Company Information
13.5.2 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 SD Biosensor Main Business Overview
13.5.5 SD Biosensor Latest Developments
13.6 Ellume
13.6.1 Ellume Company Information
13.6.2 Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ellume Main Business Overview
13.6.5 Ellume Latest Developments
13.7 InBios
13.7.1 InBios Company Information
13.7.2 InBios Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.7.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 InBios Main Business Overview
13.7.5 InBios Latest Developments
13.8 Celltrion
13.8.1 Celltrion Company Information
13.8.2 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Celltrion Main Business Overview
13.8.5 Celltrion Latest Developments
13.9 AESKU.GROUP
13.9.1 AESKU.GROUP Company Information
13.9.2 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AESKU.GROUP Main Business Overview
13.9.5 AESKU.GROUP Latest Developments
13.10 ROCHE
13.10.1 ROCHE Company Information
13.10.2 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ROCHE Main Business Overview
13.10.5 ROCHE Latest Developments
13.11 BD
13.11.1 BD Company Information
13.11.2 BD Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 BD Main Business Overview
13.11.5 BD Latest Developments
13.12 OraSure Technologies
13.12.1 OraSure Technologies Company Information
13.12.2 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 OraSure Technologies Main Business Overview
13.12.5 OraSure Technologies Latest Developments
13.13 Clip Health
13.13.1 Clip Health Company Information
13.13.2 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Clip Health Main Business Overview
13.13.5 Clip Health Latest Developments
13.14 LumiraDx
13.14.1 LumiraDx Company Information
13.14.2 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 LumiraDx Main Business Overview
13.14.5 LumiraDx Latest Developments
13.15 Princeton BioMeditech Corporation
13.15.1 Princeton BioMeditech Corporation Company Information
13.15.2 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Princeton BioMeditech Corporation Main Business Overview
13.15.5 Princeton BioMeditech Corporation Latest Developments
13.16 RapiGEN Inc.
13.16.1 RapiGEN Inc. Company Information
13.16.2 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 RapiGEN Inc. Main Business Overview
13.16.5 RapiGEN Inc. Latest Developments
13.17 Orient Gene
13.17.1 Orient Gene Company Information
13.17.2 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Orient Gene Main Business Overview
13.17.5 Orient Gene Latest Developments
13.18 Wondfo Biotech
13.18.1 Wondfo Biotech Company Information
13.18.2 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Wondfo Biotech Main Business Overview
13.18.5 Wondfo Biotech Latest Developments
13.19 Ihealth (Andon Health)
13.19.1 Ihealth (Andon Health) Company Information
13.19.2 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Ihealth (Andon Health) Main Business Overview
13.19.5 Ihealth (Andon Health) Latest Developments
13.20 Wantai BioPharm
13.20.1 Wantai BioPharm Company Information
13.20.2 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Wantai BioPharm Main Business Overview
13.20.5 Wantai BioPharm Latest Developments
13.21 Biotest Biotech
13.21.1 Biotest Biotech Company Information
13.21.2 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Biotest Biotech Main Business Overview
13.21.5 Biotest Biotech Latest Developments
13.22 Shenzhen YHLO Biotech
13.22.1 Shenzhen YHLO Biotech Company Information
13.22.2 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Shenzhen YHLO Biotech Main Business Overview
13.22.5 Shenzhen YHLO Biotech Latest Developments
13.23 Vazyme Biotech
13.23.1 Vazyme Biotech Company Information
13.23.2 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Vazyme Biotech Main Business Overview
13.23.5 Vazyme Biotech Latest Developments
13.24 EasyDiagnosis Biomedicine
13.24.1 EasyDiagnosis Biomedicine Company Information
13.24.2 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 EasyDiagnosis Biomedicine Main Business Overview
13.24.5 EasyDiagnosis Biomedicine Latest Developments
13.25 Beijing Hotgen Biotech
13.25.1 Beijing Hotgen Biotech Company Information
13.25.2 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Beijing Hotgen Biotech Main Business Overview
13.25.5 Beijing Hotgen Biotech Latest Developments
13.26 Assure Tech
13.26.1 Assure Tech Company Information
13.26.2 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Assure Tech Main Business Overview
13.26.5 Assure Tech Latest Developments
13.27 Hangzhou AllTest Biotech
13.27.1 Hangzhou AllTest Biotech Company Information
13.27.2 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Hangzhou AllTest Biotech Main Business Overview
13.27.5 Hangzhou AllTest Biotech Latest Developments
13.28 ACON Biotech
13.28.1 ACON Biotech Company Information
13.28.2 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 ACON Biotech Main Business Overview
13.28.5 ACON Biotech Latest Developments
13.29 BGI Genomics
13.29.1 BGI Genomics Company Information
13.29.2 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 BGI Genomics Main Business Overview
13.29.5 BGI Genomics Latest Developments
13.30 Lepu Medical Technology
13.30.1 Lepu Medical Technology Company Information
13.30.2 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Offered
13.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
13.30.4 Lepu Medical Technology Main Business Overview
13.30.5 Lepu Medical Technology Latest Developments
14 Research Findings and Conclusion